Thank you very much, Chair.
I'll start my line of questioning with Dr. Morgan and Dr. Gagnon.
You both are experts in pharmacare. You've studied this. Can you talk about the impact of the lack of a pharmacare plan on the general health of a population? We can talk about Canada. What's the impact? I'm assuming it's negative. If it is negative, in what ways does that manifest itself?
Dr. Gagnon, perhaps we can start with you first.